17 March 2017 | Precision diabetes: learning from monogenic diabetes | Hattersley, AT; Patel, KA |
24 March 2017 | A Low-Frequency Inactivating Akt2 Variant Enriched in the Finnish Population is Associated With Fasting Insulin Levels and Type 2 Diabetes Risk | Manning, A; Highland, HM; Gasser, J; et al. |
13 June 2017 | Management of sulfonylurea treated monogenic diabetes in pregnancy: implications of placental Glibenclamide transfer | Shepherd, M; Brook, AJ; Chakera, AJ; et al. |
2012 | The role of inflammatory pathway genetic variation on maternal metabolic phenotypes during pregnancy | Urbanek, M; Hayes, MG; Lee, H; et al. |
1 May 2010 | Variants in ADCY5 and near CCNL1 are associated with fetal growth and birth weight | Freathy, RM; Mook-Kanamori, DO; Sovio, U; et al. |
31 March 2016 | Successful transfer to sulfonylureas in KCNJ11 neonatal diabetes is determined by the mutation and duration of diabetes | Babiker, T; Vedovato, N; Patel, K; et al. |
1 July 2013 | The clinical utility of C-peptide measurement in the care of patients with diabetes | Jones, AG; Hattersley, AT |
15 February 2018 | Pharmacogenomics in diabetes: outcomes of thiamine therapy in TRMA syndrome | Habeb, AM; Flanagan, SE; Zulali, MA; et al. |
17 July 2018 | PLIN1 haploinsufficiency is not associated with lipodystrophy | Laver, TW; Patel, KA; Colclough, K; et al. |
22 December 2017 | Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity. | Turcot, V; Lu, Y; Highland, HM; et al. |